Clinical relevance of cholesterol homeostasis genes in colorectal cancer.
Accumulation of cholesterol is a well-known feature in cancer. Preclinical studies suggest the contribution of various cholesterol regulators in CRC. However, their clinical relevance remains poorly understood. The aim of the present study is to evaluate the expression of these modulators in CRC and elucidate their diagnostic and prognostic value. mRNA levels of HMGCR, SREBF2, NR1H3 and NR1H2 were downregulated in tumors in local and TCGA cohort. The expression of LDLR, ABCA1 and SCARB1 was not consistent in the two cohorts. Western Blot analysis showed the increased levels of LDLR and reduced levels of LXR in early stage patients. Tumoral SREBP2 levels were enhanced in early stage whereas decreased in late stage. The individual expression of HMGCR, SREBF2, NR1H3 and NR1H2 did not have the potential to be used as independent prognostic marker, however, the combined expression of these genes associated with poor clinical outcome independent of lymph node metastasis, distant metastasis and advanced stage. This work sheds light on deregulation of cholesterol uptake and efflux pathways and provides novel leads in the development of biomarkers and therapeutic regimens that can detect and target CRC at initial stages.
['Sharma|Bhoomika|B|', 'Gupta|Vikas|V|', 'Dahiya|Divya|D|', 'Kumar|Hemanth|H|', 'Vaiphei|Kim|K|', 'Agnihotri|Navneet|N|']
D002784:Cholesterol D015179:Colorectal Neoplasms D005260:Female D015972:Gene Expression Regulation, Neoplastic D006801:Humans D006903:Hydroxymethylglutaryl CoA Reductases D000071518:Liver X Receptors D008297:Male D008875:Middle Aged D011379:Prognosis D051782:Sterol Regulatory Element Binding Protein 2
HMGCR SREBF2 LDLR Cholesterol efflux Liver X receptors